JO
CARM

John Overdeck’s Carisma Therapeutics CARM Stock Holding History

John Overdeck’s Portfolio CARM Stock Details CARM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-34,141
Closed -$33.5K – 3230
2024
Q3 		$33.5K Buy
+34,141
New +$37K ﹤0.01% 2990
2024
Q2 		– Sell
-40,602
Closed -$92.2K – 3054
2024
Q1 		$92.2K Buy
40,602
+15,209
+60% +$36.5K ﹤0.01% 2840
2023
Q4 		$74.4K Buy
+25,393
New +$75.5K ﹤0.01% 2969
2022
Q1 		– Sell
-24,974
Closed -$407K – 2863
2021
Q4 		$407K Sell
24,974
-113,696
-82% -$2.29M ﹤0.01% 3433
2021
Q3 		$2.2M Sell
138,670
-18,859
-12% -$905K ﹤0.01% 1899
2021
Q2 		$14.6M Sell
157,529
-3,362
-2% -$214K 0.03% 623
2021
Q1 		$8.37M Buy
160,891
+131,183
+442% +$6.19M 0.02% 778
2020
Q4 		$802K Buy
29,708
+7,849
+36% +$199K ﹤0.01% 2167
2020
Q3 		$612K Buy
21,859
+20,282
+1,286% +$406K ﹤0.01% 2086
2020
Q2 		$23K Buy
1,577
+245
+18% +$3.3K ﹤0.01% 2862
2020
Q1 		$15K Sell
1,332
-2,035
-60% -$33.3K ﹤0.01% 2980
2019
Q4 		$70K Buy
+3,367
New +$77.4K ﹤0.01% 3547
2019
Q1 		– Sell
-1,212
Closed -$34K – 3046
2018
Q4 		$34K Buy
+1,212
New +$38.7K ﹤0.01% 2879
2018
Q3 		– Sell
-1,985
Closed -$77K – 3191
2018
Q2 		$77K Buy
+1,985
New +$87.5K ﹤0.01% 3218
2015
Q3 		– Sell
-1,644
Closed -$93K – 2238
2015
Q2 		$93K Buy
+1,644
New +$232K ﹤0.01% 2718

Other funds holding CARM

MC
Merck & Co Rahway, New Jersey $526M AUM 175.27% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AIIC
AJU IB Investment Company Seoul, South Korea $30.5M AUM 128.96% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

John Overdeck's CARM Position: Q4 2024 in Review

John Overdeck sold out of Carisma Therapeutics (CARM) in Q4 2024, closing a stake of 34,141 shares — an estimated $33.5K sold.

John Overdeck first reported a position in CARM in Q2 2015 and held it in 15 quarters. The position peaked at $14.6M in Q2 2021. 41 funds tracked by Wall St. Rank hold CARM as of Q4 2024.

  • John Overdeck reported no remaining Carisma Therapeutics position as of Q4 2024 after selling out during the quarter.
  • John Overdeck sold 34,141 Carisma Therapeutics shares in Q4 2024, an estimated $33.5K.
  • John Overdeck first reported a position in Carisma Therapeutics in Q2 2015 and held it in 15 quarters.
  • John Overdeck's Carisma Therapeutics position peaked at $14.6M in Q2 2021.
  • 41 funds tracked by Wall St. Rank held Carisma Therapeutics as of Q4 2024.

Based on Two Sigma Investments's 13F filing for Q4 2024, filed 14 Feb 2025.